# OnCo record paper-nct04025879-n-engl-j-med-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04025879-n-engl-j-med-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04025879-n-engl-j-med-2024" ;
  schema:name "Perioperative Nivolumab in Resectable Lung Cancer"@en ;
  schema:description "Published report from the CheckMate 77T trial registered as NCT04025879, in New England Journal of Medicine (2024), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04025879-n-engl-j-med-2024/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa2311926>, <https://pubmed.ncbi.nlm.nih.gov/38749033/>, <https://europepmc.org/article/MED/38749033>, <https://clinicaltrials.gov/study/NCT04025879> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa2311926> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Cascone T, Awad MM, Spicer JD, et al." ;
  onco:trials <https://onco.cc/trials/nct04025879/> ;
  onco:journals <https://onco.cc/journals/nejm/> .